Delivery Order SPE2DB22D3501-SPE2DB24FXC84

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $7,356.52 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4,566,185,907 units of 1% isosulfan blue dye vials (5 ml). This delivery order is a part of a larger indefinite delivery contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, with ID SPE2DB22D3016|SPE2DB23FAYP4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,371.18 Firm Fixed Price Delivery Order contract is for the provision of Isosulfan Blue 1% Vial, 5mL, a medical product used in various medical procedures. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of Isosulfan Blue 1% Vial 5mL to the Defense Logistics Agency (DLA). The $10,227.28 firm fixed-price delivery order has a completion date of December 17, 2021 and was awarded on December 16, 2021. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560482684 - ISOSULFAN BLUE 1% VIAL 5ML. The $8,022.57 firm fixed price delivery order has an ultimate completion date of April 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Isosulfan Blue 1% Vial 5ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $13,047.60 and a period of performance through January 17, 2025. The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,502.14 firm fixed-price delivery order is for the supply of ISOSULFAN BLUE 1% VIAL 5ML, with a completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FM1L0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,942.15 firm-fixed-price delivery order is for the supply of 4555811271 - ISOSULFAN BLUE 1% VIAL 5ML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,041.15 firm fixed-price delivery order is for the supply of 4565289127 BLUDIGO 40 MG/5 ML AMPULE 5ML, a pharmaceutical product. The contract has a period of performance through July 31, 2024 and was awarded on July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $157,682.91 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price and runs through November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,714.71 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXC84
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of Isosulfan Blue 1% Vial 5ML. The $47,858.81 firm fixed price contract has a completion date of September 27, 2024. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, such as a $999,999,999 IDC with DLA Troop Support Medical valid through December 2025, and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024. These IDCs enable efficient procurement of essential pharmaceutical and medical supplies to support healthcare needs across military, veterans, and other federal programs.

Generated 12/26/24, 9:01 AM